Rui Guo1
Yuanqing He
Haile Ma- 1College of Food Science and Biological Engineering, Jiangsu University, Zhenjiang, China
- 2The Laboratory Animal Research Center, Jiangsu University, Zhenjiang, China
Cancer, as one of the most life-threatening diseases, has attracted the attention of researchers to develop drugs with minimal side effects. The bioactive macromolecules, such as the polysaccharides, are considered the potential candidates against cancer due to their anti-tumor activities and non-toxic characteristics. The present review provides an overview on polysaccharides' extraction, isolation, purification, mechanisms for their anti-tumor activities, structure-activity relationships, absorption and metabolism of polysaccharides, and the applications of polysaccharides in anti-tumor therapy. Numerous research showed extraction methods of polysaccharides had a significant influence on their activities. Additionally, the anti-tumor activities of the polysaccharides are closely related to their structure, while molecular modification and high bioavailability may enhance the anti-tumor activity. Moreover, most of the polysaccharides exerted an anti-tumor activity mainly through the cell cycle arrest, anti-angiogenesis, apoptosis, and immunomodulation mechanisms. Also, recommendations were made to utilize the polysaccharides against cancer.
Introduction
Cancer, as one of the most life-threatening diseases, is mainly induced by irregularities in the cell division, which can be governed by genetic, environmental, and chemical factors (1). The global epidemiological survey (2018) estimated that the cumulative risks of morbidity and mortality due to cancer were 21.4 and 17.7%, respectively (2). Currently, surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy have been developed to mitigate and treat cancer at different stages. However, these methods are still accompanied by drawbacks and side-effects, which could negatively impact the lives of patients with cancer (3). Therefore, developing new nontoxic drug molecules for cancer therapy is one of the major challenges of the researchers.
Bioactive compounds have been proven to be a potent anti-tumor agent, which exerts pleiotropic and synergistic effects with chemotherapy drugs, and targets multiple pathways of cancer (4). As one of the basic substances of life, polysaccharides are well-known for their anti-oxidation, immunomodulatory, anti-tumor, anti-inflammatory, and hypoglycemic activity (5–9). Since the discovery of anti-tumor activity in yeast polysaccharides in 1950, multiple types of polysaccharides with anti-tumor activity have been identified (10). It was demonstrated that Trametes versicolor (Synn. Coriolus versicolor) polysaccharides, fucoidan, and sepia Ink polysaccharides could be applied as adjuvant therapies of cancer, which usually possess low levels of toxicity and have high safety (11–13). Furthermore, polysaccharides could promote the recovery of patients with cancer (14, 15). It was observed that concomitant administration of fungal β-glucan, with chemo or radiotherapy, reduced the immune depression caused by such treatments or accelerated the production of white blood cells (16). Moreover, when co-administered with cyclophosphamide (CY), polysaccharides extracted from Angelica sinensis (AP) had cytoprotective effects on the hematopoietic and gastrointestinal tissues in patients with cancer (17). Therefore, it is of great significance to develop polysaccharides with better anti-tumor activities and minor side effects. Currently, natural polysaccharides have been extensively investigated, while the data concerning the mechanism of polysaccharides with anti-tumor activity and application of anti-tumor therapy were scattered. In this view, a review on natural polysaccharides, with anti-tumor activity and their mechanism for therapeutic application, is necessary. Moreover, the structure-activity relationship and the absorption and metabolism of polysaccharides with better anti-tumor activity have not been reviewed, which might limit their exploitation and utilization. Thus, the present review was conducted to summarize the extraction and the purification technology, the structure-activity relationships, and the absorption and metabolism of polysaccharides with better anti-tumor activity. Furthermore, the application of polysaccharides as anti-tumor therapy and their potential mechanisms were explored. Also, the recommendations were made to better utilize these natural products as an anti-tumor therapy. This review could contribute to a deeper understanding of polysaccharides as one type of new functional food or ingredients for human health.
Extraction, Isolation, and Purification of Polysaccharides
With the application of polysaccharides in disease treatment and health improvement, the foremost step is to extract the natural product in its high purity and quality. Furthermore, natural polysaccharides experience physiochemical and functional changes during extraction, and thus, selection of an appropriate condition is necessary (18).
Extraction
Currently, the most common methods for the extraction of polysaccharides include hot water extraction (HWE), ultrasound-assisted extraction (UAE), supercritical fluid extraction (SFE), ultrasound and microwave-assisted extraction (UMAE), and enzyme-assisted extraction (EAE). The effects of different extraction methods on polysaccharide activity are shown in Table 1. Therefore, the appropriate extraction methods could be screened out according to the characteristics of different polysaccharides. Furthermore, different extraction methods are helpful to prepare polysaccharides with better anti-tumor activity through changing the native polysaccharides' intrinsic viscosity and spatial conformation (19). Zhu et al. reported that the polysaccharides from Cordyceps gunnii (C. gunnii) mycelia, obtained by microwave-assisted extraction (MAE), could transform their spatial conformation to clumpy structures and exhibited better anti-tumor activity than by HWE and UAE (20). Meanwhile, the optimal extraction conditions for polysaccharides have played a key role in obtaining the extract of high quality with functional attributes. In an experiment of extracting crude ginger polysaccharides (GPs) with different extraction methods, an ultrasonic cell grinder extraction (UCGE) exhibited a stronger inhibitory effect (56.843 ± 2.405%) on three tumor cell lines, followed by HWE and EAE (21). It implies that polysaccharides with enhanced activities may be obtained by selecting suitable extraction methods.
Table 1. Advantages and disadvantages of extraction methods of polysaccharides.
Isolation and Purification
The extract is a complex mixture of pigments, proteins, inorganic salts, lignin, bioactive compounds, etc. (33). The impurities need to be removed to identify the polysaccharides' structure and functional activity (34). Currently, the sevag method, trichloro trifluoroethane method, and trichloroacetic acid (TCA) methods could be used for the removal of protein, while anion exchange macroporous resin, hydrogen peroxide (H2O2), organic solvents successive rinse, and activated carbon adsorption could be used to remove pigments (35). There are several basic methods for purifying the polysaccharides mixture, as highlighted in Table 2.
Table 2. Advantages and disadvantages of isolation and purification methods of polysaccharides.
At present, the optimized combination of multiple methods may be more effective to obtain the highly-purified polysaccharides with multiple bioactivities (46). A binary system with hot water and supercritical CO2 has been developed to obtain extracts that are rich in anti-oxidant polysaccharides, which could increase the protection against oxidative damage induced by H2O2 tested in the HepG2 cells model (47). The purified water-soluble intracellular polysaccharides (IPSW-1) obtained by fractional ethanol precipitation, followed by ion-exchange and size exclusion chromatography, showed the prominent inhibitory effect on the HepG2 cell line with a 39% inhibition rate at the concentration of 70 μg/ml (48). The crude polysaccharides obtained from the brown seaweed Sargassum pallidum under supercritical CO2 extraction and ultrasonic-aid extraction were purified by membrane technology and diethylaminoethyl (DEAE) cellulose-52 chromatography. The polysaccharide fractions (SP-3-2) showed higher anti-tumor activity against the HepG2 cells than a blank control at 1 mg/ml concentration (49). After HWE (15 L/kg) for 2 h, followed by ethanol purification, polysaccharides from sporoderm-broken spore of G. lucidum (SGP) could improve the chemotherapy side effects by relieving a small intestinal barrier injury caused by paclitaxel (PTX) (50).
The Mechanisms of Anti-Tumor Effects of Polysaccharides
Numerous studies have shown that the most common mechanisms of anti-tumor polysaccharides include cell cycle arrest, anti-angiogenesis, and apoptosis, which exert direct tumor-killing capacities. Alternatively, immunomodulation could protect the immune system and induce indirect tumor-killing effects (51, 52). The mechanisms of polysaccharides' anti-tumor activity are shown in Figure 1.
Figure 1. Summary of anti-tumor mechanisms of polysaccharides.
Cell Cycle Arrest
The cell cycle is defined as the whole process of cell division, including the interphases (G1, G0 S, and G2) and mitotic phases (M1 and M2). Numerous studies showed that the proliferation of tumor cells could be prevented by breaking the cell cycle at any point of the G1-S-G2-M phases (53). Cell cycle arrest at G0/G1 and G2/M phases could decrease the number of cells that subsequently enter the S-phase, which was attributed to inhibiting the cyclin-dependent kinases and activation of the cell cycle checkpoints, followed by the generation of subsequent deaths of the cancer cell lines (54). One recent study reported that the Hawthorn (Crataegus.) polysaccharides (HPS) treatment on human colon cancer cell line HCT116 for 12 h has decreased the mRNA expressions of Cyclin A1, Cyclin D1, Cyclin E1, and CDK (cyclin-dependent kinase) 1/2, resulting in cycle cell arrest in the S and G2/M phases (55). Jie et al. also discovered that Auricularia polytricha polysaccharides (APPs)-mediated cell cycle arrest at G0/G1 phase, mainly through inhibition of CDK/cyclin complexes formation, downregulating cyclin A, cyclin D, and CDK2, and activating p21 in a p53-dependent (p53 is an effective tumor suppressor) event in a human lung cancer cell line, which is the A549 (56). Thus, the regulation of cell cycle-related genes could inhibit the malignant growth of cancer cells by arresting the cell cycle progression.
Anti-angiogenesis
Angiogenesis, the process of new blood vessel formation from pre-existing vasculature, is crucial for malignant tumor growth and tumor metastasis (57). It is widely recognized that inhibiting angiogenesis is an efficient strategy for treating various cancers in the early stages of tumor growth (58, 59).
Epidermal Growth Factor Receptor (EGFR) overexpression has been proven to be closely correlated with the pathogenesis of multiple malignancies (60). In addition, vascular endothelial growth factor (VEGF) played an important role in tumor-induced angiogenesis (61). Treatment with the water-soluble polysaccharide (PTP) (10, 20, and 40 mg/kg) prepared from the roots of Polygala tenuifolia could exert potential anti-angiogenesis effects by significantly downregulating the protein and mRNA levels of EGFR, VEGF, and CD34 (Hematopoietic progenitor cell antigen) in the tumor-bearing BALB/c mice, resulting in the suppression of tumor growth (62). Ren et al. conducted a tube formation assay and chick embryo chorioallantoic membrane (CAM) assay and demonstrated that dandelion polysaccharide (DP) could induce an anti-angiogenesis in vitro and in vivo. Furthermore, DP inhibited the expression of VEGF and HIF-1α (a hypoxia response protein) by targeting PI3K/AKT pathway, thereby downregulating the angiogenesis, which was believed to be a potential strategy to control tumor growth (63).
Apoptosis
Apoptosis is a physiological process of programmed cell death that plays an important role in cancer treatment (52). Multiple polysaccharides have been recognized to induce apoptosis of cancer cells. A group of cysteine proteases (caspase-3, caspase-8, and caspase-9), which are key executioners for propagating the apoptotic signal, could trigger caspase-dependent apoptosis (64). In the case of Cordyceps sinensis polysaccharide (CSP), the activation of caspase-8 and caspase-3 induced apoptosis in human colon cancer cell line HCT116 (65). Also, treatment on A549 cells with Hedyotis diffusa polysaccharide (HDP) for 48 h could promote the release of cytochrome C from mitochondria into the cytosol, increase the pro-apoptotic Bax protein expression, unchanged anti-apoptotic Bcl-2 protein, and increase the Bax/Bcl-2 ratio in A549 cells. Moreover, the activated caspase-9 and −3 contribute to the mitochondrial-dependent apoptotic pathway (66). Previous studies also demonstrated that the alcohol-soluble polysaccharides of the rhizome of Atractylodes macrocephala Koidz (APA) promoted apoptosis on human esophageal cancer cells, the Eca-109, by a mitochondrial pathway (67). Furthermore, Fas/Fas ligand (Fas/FasL) played a significant role in tumorigenesis (68). The PGL (Gracilariopsis lemaneiformis polysaccharide) was found to exert a potential effect against a neoplastic disease by upregulating the Fas/FasL's protein and mRNA expressions, resulting in a Fas/FasL-dependent apoptosis in tumor cells (69).
Immunomodulation
It has been proven that the anti-tumor activity was closely related to immunomodulation (70). The polysaccharides could activate macrophages, T-lymphocytes, B-lymphocytes, natural killer cells, and cytokines that are closely related to the killing of the tumor, such as tumor necrosis factor (TNF-α), interferon (IFN-γ), and interleukins (IL-2, IL-4, IL-6, and IL-12) (71). The anti-tumor immune response regulated by macrophages may be the first line of defense against tumors (59). Multiple polysaccharides could induce robust immune responses against tumors. They may work independently to give anti-tumor activity through the upregulation of the surface accessory molecules of resident macrophages and dendritic cells (DCs) to promote secreting cytokines, which increased the serum IL-2 levels. This is observed in the case of Epimedium koreanum Nakai polysaccharides (EPS) treatment (72). Moreover, Artemisia argyi polysaccharides (FAAP-02) were reported to improve anti-tumor activity by promoting the production of lymphocyte, TNF-α, IL-2, IL-4, IL-6, and IL-12. Thus, FAAP-02 could improve the 5-fluorouracil's side-effects when co-administered with 5-fluorouracil (73).
Other Pathways
In addition to the mechanisms discussed above, the nitric oxide (NO) pathway may also be a mechanism of the anti-tumor polysaccharides. Several polysaccharides are reported to stimulate macrophages to produce NO, which could directly act on tumor cells via upregulation of inducible NO synthase (iNOS) activity (51). Reactive oxygen species (ROS) involved in the transformation, tumor survival, proliferation, invasion, and metastasis of cancer cells and polysaccharides could suppress ROS to prevent activation of pro-tumorigenic signaling pathways (74, 75). The ROS-centered pathways include mitochondrial autophagy, mitogen-activated protein kinase (MAPK), and transcription factor-related pathways like nuclear factor kappa-B (NF-κB) and hypoxia-inducible factor (HIF). These pathways could be utilized with or without the further involvement of inflammatory and death receptor pathways (76). This may be helpful in the prevention of cancer in healthy individuals, as observed with the administration of Ganoderma lucidum polysaccharide (77). So far, the molecular mechanisms of polysaccharides are mostly investigated in vitro or animal models, and further research on clinical investigations is needed (53).
Structure-Activity Relationship and Bioavailability of Polysaccharides
Structural diversity (including primary, secondary, tertiary, and quaternary structures) is one of the important factors affecting the anti-tumor activity of the polysaccharides (78). The primary structure includes the composition of monosaccharides, the types of glycoside bonds, the order of connection, heteropolar carbon configuration, molecular weight, position and length of branches, and degree of substitution (79). The secondary structure of polysaccharide chains (mainly including helical structure) is described as the conformation of individual monosaccharide residues and the geometry of their linkage to each other by the glycosidic bonds (80). The tertiary and quaternary structures are the arrangement of single units (based on secondary structure) within a complex built by non-covalent interactions (hydrogen bonds, van der Waals forces, etc.) (78). The main findings of the different studies concerning the structure, modification, and bioavailability of the anti-tumor polysaccharides will be summarized in this section. The types and structural diversity of polysaccharides are shown in Table 3. However, the characteristics of the complex structure of the polysaccharides require a lot of work by combining the various analytical methods and the more precise instruments. There are few studies on the analysis of the higher space structure of polysaccharides, and further research on the structure-activity relationships needs to be conducted (81).
Table 3. Types and structural diversity of polysaccharides.
Structure-Activity Relationship of Polysaccharides
The structural variability of a polysaccharide, such as the location of the monosaccharide residues, the position of glycosidic linkages, and the sequence of monosaccharide residues, are closely associated with the biological activity (59). Currently, the structure of the polysaccharides could be preliminarily analyzed via various methods, including molecular weight determination, spectral analysis, monosaccharide composition analysis, etc. A detailed investigation of the chemical structure and chain conformation could be the hotspot of structure-activity research on anti-tumor polysaccharides. The polysaccharides, with the main chain consisting of β-(1 → 3)-glucans and additional β-(1 → 6) branches, could enhance their immunostimulatory and exhibit a prominent anti-tumor activity by promoting the interaction with specific receptors (82). The A. pullulans-derived β-glucan could exhibit an anti-tumor activity by enhancing the interferon-gamma (IFN-γ) production and the NK cell activity by triggering the intestinal immunity (83). In addition, the Grifola frondosa polysaccharide, consisting of β-(1 → 3)-linked glucan branched with β-(1 → 6) glucosides, could be used as an immune-adjuvant therapy for cancers (84). The presence of hydrophilic (polyhydroxylated) groups, located outside on the surface of the triple helix, could also be important for the anti-tumor activity by increasing the immune-competent cell activity (70). Zhang et al. proved that the triple-helix conformation plays an important role in enhancing the anti-tumor effects of the lentinan. The triple-helix sample effectively inhibited the growth of Sarcoma 180, a solid tumor with the inhibition ratio of 49.5%, close to that of 5-fluorouracil (50.5%). In contrast, the bioactivity (12.3%) of its single flexible chains almost disappeared (85). The presence of branches could regulate different chain conformations, and the degree of the branch (DB) was also found crucial for polysaccharides' activity (84). It was discovered that the anti-tumor activity has rapidly dropped when the branching reached up to 9.3%, then, slightly increased as the branching degree of M-levan further decreased in HepG2 cell lines (86).
Modification and Anti-tumor Activity
The inherent structure of polysaccharides may partly limit its anti-tumor activity. The structural changes (including molecular weight, types of substituent groups, dimensional structure, etc.) caused by the molecular modification could improve the bioactivities of polysaccharides and promote the application of polysaccharides (15, 87). Molecular modification could hold changes in the steric hindrance and electrostatic repulsion, while the flexion and the extension of polysaccharide chains and the water solubility impact the bioactivities (88). In this section, the current modification methods of polysaccharides were compared (Table 4), which exerted different effects on the activity of polysaccharides.
Table 4. The different modifications of polysaccharides.
Currently, the modification methods mainly focus on the chemical modification of polysaccharides. It was shown that sulfate modification of polysaccharides could enhance the anti-tumor activity by increasing their immune-stimulating activity (98). Jiang et al. reported that the polysaccharide from Dimocarpus longan Lour. (LP1) and its sulfated derivative (LP1-S) stimulated the proliferation of lymphocytes and the macrophage function, which play an important role in the anti-tumor activity, while the LP1-S had the better immunopotentiation (99). Furthermore, phosphorylation is the most common modification of increasing the anti-tumor activity (100, 101). After phosphorylation of polysaccharides, the charged phosphate groups could improve water solubility, change molecular weight, and modify chain conformation of polysaccharides, resulting in the alteration of biological activities (102). The phosphorylated polysaccharides (P-DIP), obtained from the natural polysaccharides in Dictyophora indusiata (DIP), also showed significant inhibitory effects on the growth of MCF-7 and B16 tumor cells, while DIP had no inhibiting effects on them (103). The selenylation polysaccharides can increase antioxidant effects and reduce cancer risk (104). The selenized polysaccharides from alfalfa (Se-RAPS-2) has superior anti-tumor activity than the two native polysaccharides (RAPS-1 and RAPS-2), and the inhibition ratios of RAPS-1, RAPS-2, and Se-RAPS-2 on HepG2 cells were 30.35, 19.81, and 38.70% at a concentration of 100 μM, respectively (105).
Absorption and Metabolism of Polysaccharides
The active ingredient, either in food or medicine, commonly works after being absorbed and metabolized. The oral route is one of the most common routes of administration for food and medicine. Polysaccharides could be digested and absorbed in the gastrointestinal tract after oral administration, and the upper small intestine is the main absorption site (106). Zhang et al. found that Cyanine7 amine-labeled polysaccharides, extracted from Smilax china L. (Cy7-SCLP), could be diffused through the mucus barriers and absorbed in the small intestine. Furthermore, Cy7-SCLP could be absorbed after oral administration through endocytosis process mediated by macropinocytosis pathway and clathrin- and caveolae (or lipid raft)-related routes, and then circulated into blood (107). A modified citrus pectin (MCP) has the properties of a low-molecular-weight degree of esterification, which could be absorbed from the small intestinal epithelium, and then enter the circulation. Also, the MCP is Galectin-3 inhibitors, thus, conducive to decelerating the cancer metastasis (108). Some polysaccharides for the energy supply are directly absorbed into the small intestine and metabolized. Cao et al. discovered that Poria cocoa polysaccharide was mainly degraded into stable oligosaccharide fragments in gastric juice, and then, absorbed in the intestine in rats (109).
Fermentation in the large intestine is the main metabolism method of complex polysaccharides (including non-starch polysaccharides, resistant starches, and dietary fiber in food), which could not be digested directly by humans (110). The gut microbiome also played an important role in digesting polysaccharides (111). The gut bacteria could degrade the complex polysaccharides to generate gas, heat, and short-chain fatty acids like butyrate and propionate (112, 113). This metabolic process could improve immune functions and inhibit the occurrence of tumors. In addition, some degradation products of polysaccharides had protective metabolites, which could reduce the risk of cancer. For instance, the butyrate could modulate the action of PKC (protein kinase C) by activating the AP-1 signaling pathway, which could promote the apoptosis of colon cancer cells (114).
However, the multiple polysaccharides are large and complex molecules that cannot be easily degraded during human digestion. Their large size prevents intestinal absorption, resulting in their poor bioavailability and anti-tumor activity (111, 115). The factors including bioaccessibility, absorptivity, and metabolic conversion rate usually limit the oral bioavailability of active ingredients (116). Therefore, various research was conducted on modifications of polysaccharides to improve their bioavailability, as summarized in Table 5 (117–119).
Table 5. Methods for improving the bioavailability of polysaccharides.
Application of Polysaccharides with Anti-Tumor Activities in Drugs and Food
The polysaccharides' application in food and drugs is a research hotspot due to their significant biocompatibilities and anti-tumor activity. This section focuses on the applications of anti-tumor polysaccharides that were studied in the last 5 years as drugs and food.
Drugs
Chemotherapy is one of the main therapies for cancer treatment. Current chemotherapeutic drugs are accompanied by larger side effects, such as impairing the immune system, drug resistance, and toxicity to normal tissues (120). In contrast, polysaccharides could synergistically fight tumors with chemotherapy drugs and improve the injury caused by the surgery and radiotherapy (121, 122).
Lentinan could work in tandem with other chemical drugs, and S-1/paclitaxel/lentinan; the S-1/CDDP/lentinan, S-1/lentinan, and superfine dispersed lentinan (SDL) chemotherapies for the treatment of advanced gastric cancer, pancreatic cancer, colorectal cancer, and hepatocellular carcinoma have been developed to decrease the incidence of adverse effects of chemotherapies, to improve immunity, and to extend patients' lives (123). Furthermore, Ru (flavonoid rutin), which is non-covalently complexed with fucoidan (Fu), was proved to induce apoptosis in HeLa cells via promoting nuclear fragmentation, ROS generation, and mitochondrial potential loss without significant impacts on normal cells. Hence, the Ru-Fu complex can be used as a new anti-carcinogen for cervical cancer and could be further tested on other cancer cells (124).
The polysaccharides, with the abilities of intrinsic immunomodulation, biocompatibility, biodegradability, low toxicity, and high safety, have been used as a type of adjuvants for vaccines against cancer, which could facilitate the immunogenicity of antigens, induce stronger immune responses in populations that are responding poorly to vaccination, and decrease the dosage and production cost of vaccine (125). The Ganoderma lucidum polysaccharides, which served as a potential natural therapeutic agent, were used to suppress protein synthesis and growth of tumor cells via disturbing the survival and proliferative signaling pathways (126). In 2010, the State Food and Drug Administration (SFDA) in China approved Ganoderma sinense polysaccharide (GSP) tablet as an adjunctive therapeutic drug for treating leukopenia and hematopoietic injury count caused by radiation therapy and chemotherapy (127).
Currently, polysaccharides (or derived polysaccharides) with nanoparticles (nanogels) could be synthesized via polyelectrolyte complexation (PEC), self-assembly, covalent cross-linking, and ionic cross-linking methods. The polysaccharide-based nanogels were widely used in drug delivery systems (128). To improve drug absorption and stabilize drug components, chitosan could be used as polymer-drug conjugates or chitosan-based nanocarriers, which further increased drug targeting and executed better anti-tumor effects with lesser side effects, and supported the sustained release of anti-tumor drugs in the cancer tissues (129, 130). Fucoidan has been involved in drug delivery systems (DDS). Fucoidan, in conjugation with chemotherapeutic drugs, e.g., doxorubicin (DOX), could increase the toxicity to cancer cells (around 25 %) without showing any toxicity to normal cells (131).
Functional Foods
Also, polysaccharides can be used as ingredients of functional food. Inulin (INU) polysaccharides have physiochemical properties of hydrophilicity, low molecular weight, and resistance against degradation in the stomach and intestinal fluids. The INU has been approved by the Food and Drug Administration in India for improving the nutritional values of beverages, yogurts, biscuits, and spreads as dietary fibers (132). The Stigma maydis polysaccharides have been used to produce multiple functional food, including stigma maydis beverage, stigma maydis tea, stigma maydis oral solution, and stigma maydis tablet, which have the advantages of inhibiting blood glucose levels, improving immunity, and enhancing the anti-tumor activities (133).
Present challenges hinder the wider application of polysaccharides. Many studies on safer usage, requisite toxicity, and potential mutagenicity must be conducted. Hence, the medical applications of some polysaccharides remained in the stages of clinical trials. Despite possessing potential abilities, it is necessary to pay attention to the interactions between polysaccharides and other components, thus, hindering their bioactivity. For example, it was discovered that the anti-tumor activity might be reduced when the lentinan and other biopolymers interacted with carrageenans (134). After overcoming the issues of preparation, quality standards, route of administration, and other technical problems, polysaccharides could open new applications in cancer treatment (122, 125, 135).
Conclusion
Polysaccharides could play an important role in cancer therapy, and new classes of polysaccharides with anti-tumor activity were constantly being explored in recent years. This review clearly shows that polysaccharides could be used as promising adjuvants or functional foods for cancer therapeutics through multiple pathways.
However, some challenges hinder the applications of polysaccharides. A comprehensive study on the structure-activity relationship and absorption mechanism of polysaccharides is helpful in the development of polysaccharides as commercial products. Some action mechanisms of anti-tumor polysaccharides have been illustrated in in vitro and animal experiments; however, clinical studies need to be conducted to better understand its effects and mechanisms. Nevertheless, more experiments and clinical studies on the practical application of polysaccharides are necessary to be conducted. It could be expected that polysaccharides are of great significance as tumor therapy and for improving human health.
Author Contributions
RG: writing — original draft. MC and YD: writing — review and editing. PY: visualization. MW: investigation. HZ: supervision. YH: review and project administration. HM: funding acquisition and project administration. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by grants from Jiangsu University Foundation of China (No. 07JDG016), the Laboratory Animal Association Foundation of Jiangsu (No. DWXH201910), and the Key Technology R&D Program of Zhenjiang, China (No.SH2019011).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We are grateful to the reviewers for their constructive comments on the manuscript.
References
1. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev. (2016) 25:16–27. doi: 10.1158/1055-9965.EPI-15-0578
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2018) 68:394–424. doi: 10.3322/caac.21492
3. Mun EJ, Babiker HM, Weinberg U, Kirson ED, Hoff DDV. Tumor treating fields: a fourth modality in cancer treatment. Clin Cancer Re. (2018) 24:266–75. doi: 10.1158/1078-0432.CCR-17-1117
4. Lachance JC, Radhakrishnan S, Madiwale G, Guerrier S, Vanamala JKP. Targeting hallmarks of cancer with a food-system-based approach. Nutrition. (2020) 69:110563. doi: 10.1016/j.nut.2019.110563
5. Zhao X, Lin F, Li H, Li H, Wu D, Geng F, et al. Recent advances in bioactive compounds, health functions, and safety concerns of Onion (Allium cepa L). Front Nutr. (2021) 8:669805. doi: 10.3389/fnut.2021.669805
6. Chaisuwan W, Phimolsiripol Y, Chaiyaso T, Techapun C, Leksawasdi N, Jantanasakulwong K, et al. The antiviral activity of bacterial, fungal, and algal polysaccharides as bioactive ingredients: potential uses for enhancing immune systems and preventing viruses. Front Nutr. (2021) 8:772033. doi: 10.3389/fnut.2021.772033
7. Jiang Y, Zhou W, Zhang X, Wang Y, Yang D, Li S. Protective effect of blood cora polysaccharides on H9c2 rat heart cells injury induced by oxidative stress by activating Nrf2/HO-1 signal pathway. Front Nutr. (2021) 8:632161. doi: 10.3389/fnut.2021.632161
8. Ren L, Zhang J, Zhang T. Immunomodulatory activities of polysaccharides from Ganoderma on immune effector cells. Food Chem. (2021) 340:127933. doi: 10.1016/j.foodchem.2020.127933
9. Muszyńska B, Grzywacz-Kisielewska A, Kała K, Gdula-Argasińska J. Anti-inflammatory properties of edible mushrooms: a review. Food Chem. (2018) 243:373–81. doi: 10.1016/j.foodchem.2017.09.149
10. Xu H, Huang L. Advances in research on biological activities of plant polysaccharides. J Fujian Med University. (2010) 44:79–82.
11. Li F, Luo P, Liu H. A potential adjuvant agent of chemotherapy sepia ink polysaccharides. Mar Drugs. (2018) 16:106. doi: 10.3390/md16040106
12. Habtemariam S. Trametes versicolor (Synn. Coriolus versicolor) polysaccharides in cancer therapy targets and efficacy. Biomedicines. (2020) 8:135. doi: 10.3390/biomedicines8050135
13. Hsu H-Y, Hwang P-A. Clinical applications of fucoidan in translational medicine for adjuvant cancer therapy. Clin Transl Med. (2019) 8:15. doi: 10.1186/s40169-019-0234-9
14. Wang J, Gong X. Advances in the studies on the antitumor activity and immunomodulating action of polysaccharides. Chin J Biochem Pharmaceutics. (2001) 22:52–4. doi: 10.3969/j.issn.1005-1678.2001.01.026
15. Xie L, Hong MSY. Chemical modifications of polysaccharides and their anti-tumor activities. Carbohydr Polym. (2020) 229:115436. doi: 10.1016/j.carbpol.2019.115436
16. Steimbach L, Borgmann AV, Gomar GG, Hoffmann LV, Rutckeviski R, Andrade D, et al. Fungal beta-glucans as adjuvants for treating cancer patients -a systematic review of clinical trials Clin Nutr. (2021) 40:3104–13. doi: 10.1016/j.clnu.2020.11.029
17. Hui MKC, Wu WKK, Shin VY, So WHL, Cho CH. Polysaccharides from the root of Angelica sinensis protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice. Int J Med Sci. (2006) 3:1–6. doi: 10.7150/ijms.3.1
18. Chen Y, Yao F, Ming K, Wang D, Hu Y, Liu J. Polysaccharides from traditional Chinese medicines: extraction, purification, modification, biological activity. Molecules. (2016) 21:1705. doi: 10.3390/molecules21121705
19. Li Y, Qin G, Cheng C, Yuan B, Huang D, Cheng S, et al. Purification, characterization and anti-tumor activities of polysaccharides from Ecklonia kurome obtained by three different extraction methods. Int J Biol Macromol. (2020) 150:1000–10. doi: 10.1016/j.ijbiomac.2019.10.216
20. Zhu Z, Dong F, Liu X, Lv Q, Ying Y, Liu F, et al. Effects of extraction methods on the yield, chemical structure and anti-tumor activity of polysaccharides from Cordyceps gunnii mycelia. Carbohydr Polym. (2016) 140:461–71. doi: 10.1016/j.carbpol.2015.12.053
21. Liao D, Cheng C, Liu J, Zhao L, Huang D, Chen G. Characterization and antitumor activities of polysaccharides obtained from ginger (Zingiber officinale) by different extraction methods. Int J Biol Macromol. (2020) 152:894–903. doi: 10.1016/j.ijbiomac.2020.02.325
22. Wang J, Luo J, Zha X, Feng B. Comparison of antitumor activities of different polysaccharide fractions from the stems of Dendrobium nobile Lindl. Carbohydr Polym. (2010) 79:114–8. doi: 10.1016/j.carbpol.2009.07.032
23. Wang X, Zhang D, Yin J, Nie S, Xie M. Recent developments in Hericium erinaceus polysaccharides: extraction, purification, structural characteristics and biological activities. Crit Rev Food Sci Nutr. (2019) 59:S96–S115. doi: 10.1080/10408398.2018.1521370
24. Thangam R, Suresh V, Kannan S. Optimized extraction of polysaccharides from Cymbopogon citratus and its biological activities. Int J Biol Macromol. (2014) 65:415–23. doi: 10.1016/j.ijbiomac.2014.01.033
25. Liu J, Li Y, Liu W, Qi Q, Hu X, Li S, et al. Extraction of polysaccharide from dendrobium nobile Lindl. by subcritical water extraction. ACS Omega. (2019) 4:20586–94. doi: 10.1021/acsomega.9b02550
26. Kadam SU, Tiwari BK, Donnell CPO. Application of novel extraction technologies for bioactives from marine algae. Am Chem Soc. (2013) 61:4667–75. doi: 10.1021/jf400819p
27. Sun H, Li C, Ni Y, Yao L, Jiang H, Ren X, et al. Ultrasonic/microwave-assisted extraction of polysaccharides from Camptotheca acuminata fruits and its antitumor activity. Carbohydr Polym. (2019) 206:557–64. doi: 10.1016/j.carbpol.2018.11.010
28. Chen N, Zhang H, Zong X, Li S, Wang J, Wang Y, et al. Polysaccharides from Auricularia auricula: Preparation, structural features and biological activities. Carbohydr Polym. (2020) 247:116750. doi: 10.1016/j.carbpol.2020.116750
29. Chen Y, Gu X, Huang S-q, Li J, Wang X, Tang J. Optimization of ultrasonic/microwave assisted extraction (UMAE) of polysaccharides from Inonotus obliquus and evaluation of its anti-tumor activities. Int J Biol Macromol. (2010) 46:429–35. doi: 10.1016/j.ijbiomac.2010.02.003
30. Song Y-R, Sung S-K, Jang M, Lim T-G, Cho C-W, Han C-J, et al. Enzyme-assisted extraction, chemical characteristics, and immunostimulatory activity of polysaccharides from Korean ginseng (Panax ginseng Meyer). Int J Biol Macromol. (2018) 116:1089–97. doi: 10.1016/j.ijbiomac.2018.05.132
31. Nadar SS, Rao P, Rathod VK. Enzyme assisted extraction of biomolecules as an approach to novel extraction technology: a review. Food Res Int. (2018) 108:309–30. doi: 10.1016/j.foodres.2018.03.006
32. Song Y-R, Han A-R, Park S-G, Cho C-W, Rhee Y-K, Hong H-D. Effect of enzyme-assisted extraction on the physicochemical properties and bioactive potential of lotus leaf polysaccharides. Int J Biol Macromol. (2020) 153:169–79. doi: 10.1016/j.ijbiomac.2020.02.252
33. Lyu F, Xu X, Zhang L. Natural polysaccharides with different conformations: extraction, structure and anti-tumor activity. J Mater Chem B. (2020) 8:9652–67. doi: 10.1039/D0TB01713B
34. Zhuo X, Liu W, Yang Z. Advances of the animal-original polysaccharides: extraction, purification and structure identification. Mod Chem Res. (2020) 03:44–7. doi: 10.3969/j.issn.1672-8114.2020.03.017
35. Ma W, Ji Y. Investigation on extraction,purification,structural identification and biological activity of plant polysaccharides. Grain Sci Technol Econ. (2019) 44:77–80.
36. Shi L. Bioactivities, isolation and purification methods of polysaccharides from natural products: a review. Int J Biol Macromol. (2016) 92:37–48. doi: 10.1016/j.ijbiomac.2016.06.100
37. Tang W, Liu D, Yin J, Nie S. Consecutive and progressive purification of food-derived natural polysaccharide: based on material, extraction process and crude polysaccharide. Trends Food Sci Technol. (2020) 99:76–87. doi: 10.1016/j.tifs.2020.02.015
38. Xie J, Shen M, Nie SP, Liu X, Zhang H, Xie M. Analysis of monosaccharide composition of Cyclocarya paliurus polysaccharide with anion exchange chromatography. Carbohydr Polym. (2013) 98:976–81. doi: 10.1016/j.carbpol.2013.07.011
39. Xu Y, Liu G, Yu Z, Song X, Li X, Yang Y, et al. Purification, characterization and antiglycation activity of a novel polysaccharide from black currant. Food Chem. (2016) 199:694–701. doi: 10.1016/j.foodchem.2015.12.078
40. Zhu Z, Liu X, Fang X, Sun H, Yang X, Zhang Y. Structural characterization and anti-tumor activity of polysaccharide produced by Hirsutella sinensis. Int J Biol Macromol. (2016) 82:959–66. doi: 10.1016/j.ijbiomac.2015.10.075
41. Chen G, Zhang S, Ran C, Wang L, Kan J. Extraction, characterization and antioxidant activity of water-soluble polysaccharides from Tuber huidongense. Int J Biol Macromol. (2016) 91:431–42. doi: 10.1016/j.ijbiomac.2016.05.108
42. Kasai K. Frontal affinity chromatography: an excellent method of analyzing weak biomolecular interactions based on a unique principle. Biochim Biophys Acta Gen Subj. (2021) 1685:129761. doi: 10.1016/j.bbagen.2020.129761
43. Kasai K. Frontal affinity chromatography: a unique research tool for biospecific interaction that promotes glycobiology. Proc Jpn Acad Ser B Phys Biol Sci. (2014) 90:215–34. doi: 10.2183/pjab.90.215
44. Feng S, Luan D, Ning K, Shao P, Sun P. Ultrafiltration isolation, hypoglycemic activity analysis and structural characterization of polysaccharides from Brasenia schreberi. Int J Biol Macromol. (2019) 135:141–51. doi: 10.1016/j.ijbiomac.2019.05.129
45. Saha NK, Balakrishnan M, Ulbricht M. Sugarcane juice ultrafiltration: FTIR and SEM analysis of polysaccharide fouling. J Memb Sci. (2007) 306:287–97. doi: 10.1016/j.memsci.2007.09.006
46. Ren Y, Bai Y, Zhang Z, Cai W, Flores ADR. The preparation and structure analysis methods of natural polysaccharides of plants and fungi: a review of recent development. Molecules. (2019) 24:3122. doi: 10.3390/molecules24173122
47. Barbosa JR, Freitas MMS, Oliveira LC, Martins LHS, Almada-Vilhena AO, Oliveira RM, et al. Obtaining extracts rich in antioxidant polysaccharides from the edible mushroom pleurotus ostreatus using binary system with hot water and supercritical CO2. Food Chem. (2020) 330:12173. doi: 10.1016/j.foodchem.2020.127173
48. Li S, Yang X, Ma H, Yan J, Guo D. Purification, characterization and antitumor activity of polysaccharides extracted from phellinus igniarius mycelia. Carbohydr Polym. (2015) 133 24–30. doi: 10.1016/j.carbpol.2015.07.013
49. Ye H, Wang K, Zhou C, Liu J, Zeng X. Purification, antitumor and antioxidant activities in vitro of polysaccharides from the brown seaweed Sargassum pallidum. Food Chem. (2008) 111:428–32. doi: 10.1016/j.foodchem.2008.04.012
50. Li D, Gao L, Li M, Luo Y, Xie Y, Luo T, et al. Polysaccharide from spore of ganoderma lucidum ameliorates paclitaxel-induced intestinal barrier injury: apoptosis inhibition by reversing microtubule polymerization. Biomed Pharmacotherapy. (2020) 130:110539. doi: 10.1016/j.biopha.2020.110539
51. Khan T, Date A, Chawda H, Patel K. Polysaccharides as potential anticancer agents—a review of their progress. Carbohydr Polym. (2019) 210:412–28. doi: 10.1016/j.carbpol.2019.01.064
52. Lu J, He R, Sun P, Zhang F, Linhardt RJ, Zhang A. Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review. Int J Biol Macromol. (2020) 150:765–74. doi: 10.1016/j.ijbiomac.2020.02.035
53. Ji X, Peng Q, Wang M. Anti-colon-cancer effects of polysaccharides: a mini-review of the mechanisms. Int J Biol Macromol. (2018) 14:1127–33. doi: 10.1016/j.ijbiomac.2018.03.186
54. Chen F, Ran L, Mi J, Yan Y, Lu L, Jin B, et al. Isolation, characterization and antitumor effect on DU145 Cells of a main polysaccharide in pollen of Chinese wolfberry. Molecules. (2018) 23:2430. doi: 10.3390/molecules23102430
55. Ma L, Xu GB, Tang X, Zhang C, Zhao W, Wang J, et al. Anti-cancer potential of polysaccharide extracted from hawthorn(Crataegus) on human colon cancer cell line HCT116 via cell cycle arrest and apoptosis. J Funct Foods. (2020) 64:103677. doi: 10.1016/j.jff.2019.103677
56. Yu J, Sun R, Zhao Z, Wang Y. Auricularia polytricha polysaccharides induce cell cycle arrest and apoptosis in human lung cancer A549 cells. Int J Biol Macromol. (2014) 68:67–71. doi: 10.1016/j.ijbiomac.2014.04.018
57. Liu F, Wang J, Chang AK, Liu B, Yang L, Li Q, et al. Fucoidan extract derived from undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells. Phytomedicine. (2012) 19:797–803. doi: 10.1016/j.phymed.2012.03.015
58. Lin S-P, Lee Y-T, Yang S-H, Miller SA, Chiou S-H, Hung M-C, et al. Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis. Cancer Lett. (2013) 328:226–34. doi: 10.1016/j.canlet.2012.08.036
59. Meng X, Liang H, Luo L. Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities. Carbohydr Res. (2016) 424:30–41. doi: 10.1016/j.carres.2016.02.008
60. Gui T, Shen K. The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer. Cancer Epidemiol. (2012) 36:490–6. doi: 10.1016/j.canep.2012.06.005
61. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. (1989) 246:1306–9. doi: 10.1126/science.2479986
62. Yao H, Cui P, Xu D, Liu Y, Tian Q, Zhang F, et al. water-soluble polysaccharide from the roots of Polygala tenuifolia suppresses ovarian tumor growth and angiogenesis in vivo. Int J Biol Macromol. (2018) 107:713–8. doi: 10.1016/j.ijbiomac.2017.09.043
63. Ren F, Wu K, Yang Y, Yang Y, Wang Y, Li J. Dandelion polysaccharide exerts anti-angiogenesis effect on hepatocellular carcinoma by regulating VEGF/HIF-1α expression. Front Pharmacol. (2020) 11:460. doi: 10.3389/fphar.2020.00460
64. Ho P-k, Hawkins CJ. Mammalian initiator apoptotic caspases. FEBS J. (2005) 272 5436–53. doi: 10.1111/j.1742-4658.2005.04966.x
65. Qi W, Zhou X, Wang J, Zhang K, Zhou Y, Chen S, et al. Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling. Carbohydr Polym. (2020) 237:116113. doi: 10.1016/j.carbpol.2020.116113
66. Lin L, Cheng K, Xie Z, Chen C, Chen L, Huang Y, et al. Purification and characterization a polysaccharide from Hedyotis diffusa and its apoptosis inducing activity toward human lung cancer cell line A549. Int J Biol Macromol. (2019) 122:64–71. doi: 10.1016/j.ijbiomac.2018.10.077
67. Feng Y, Ji H, Dong X, Liu A. An alcohol-soluble polysaccharide from Atractylodes macrocephala Koidz induces apoptosis of Eca-109 cells. Carbohydr Polym. (2019) 226:115136. doi: 10.1016/j.carbpol.2019.115136
68. Svandova EB, Vesela B, Lesot H, Poliard A, Matalova E. Expression of Fas, FasL, caspase-8 and other factors of the extrinsic apoptotic pathway during the onset of interdigital tissue elimination. Histochem Cell Biol. (2017) 147:497–510. doi: 10.1007/s00418-016-1508-6
69. Kang Y, Wang Z, Xie D, Sun X, Yang W, Zhao X, et al. Characterization and potential antitumor activity of polysaccharide from gracilariopsis lemaneiformis. Mar Drugs. (2017) 15 100. doi: 10.3390/md15040100
70. Bohn JA, BeMiller JN. (1 → 3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym. (1995) 28 3–14. doi: 10.1016/0144-8617(95)00076-3
71. Kuo M, Weng C, Ha C, Wu M. Ganoderma lucidum mycelia enhance innate immunity by activating NF-B. J Ethnopharmacol. (2006) 103:217–22. doi: 10.1016/j.jep.2005.08.010
72. Wang C, Feng L, Su J, Cui L, Liu D, Yan J, et al. Polysaccharides from Epimedium koreanum Nakai with immunomodulatory activity and inhibitory effect on tumor growth in LLC-bearing mice. J Ethnopharmacol. (2017) 207:8–18. doi: 10.1016/j.jep.2017.06.014
73. Bao X, Yuan H, Wang C, Liu J. Lan M. Antitumor and immunomodulatory activities of a polysaccharide from Artemisia argyi. Carbohydr Polym. (2013) 98:1236–43. doi: 10.1016/j.carbpol.2013.07.018
74. Huang G, Huang H. The derivatization and antitumor mechanisms of polysaccharides. Future Med Chem. (2017) 9:1931–8. doi: 10.4155/fmc-2017-0132
75. Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. (2016) 387:95–105. doi: 10.1016/j.canlet.2016.03.042
76. Jiao R, Liu Y, Gao H, Xiao J, So KF. The anti-oxidant and antitumor properties of plant polysaccharides. Am J Chin Med. (2016) 44: 463–88. doi: 10.1142/S0192415X16500269
77. Hu S, Huang J, Pei S, Ouyang Y, Ding Y, Jiang L, et al. Ganoderma lucidum polysaccharide inhibits UVB-induced melanogenesis by antagonizing cAMP/PKA and ROS/MAPK signaling pathways. J Cell Physiol. (2018) 234:7330–40. doi: 10.1002/jcp.27492
78. Zeng P, Li J, Chen Y, Zhang L. The structures and biological functions of polysaccharides from traditional Chinese herbs. Prog Mol Biol Transl Sci. (2019) 163:423–44. doi: 10.1016/bs.pmbts.2019.03.003
79. Jin M, Zhao K, Huang Q, Xu C, Shang P. Isolation, structure and bioactivities of the polysaccharides from Angelica sinensis (Oliv) Diels: a review. Carbohydr Polym. (2012) 89:713–32. doi: 10.1016/j.carbpol.2012.04.049
80. Xie M, Nie S. A review about the research of structure and function of polysaccharides from natural products. J Chin Inst Food Sci Technol. (2010) 10:1–11. doi: 10.16429/j.1009-7848.2010.02.035
81. Wu M, Xia W, Xu Z, Song J, Chen L, Zhang W. Review on isolation and purification, structural elucidation and biological activity of botanical polysaccharide. Chem World. (2019) 60:737–46.
82. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. (2002) 60:258–74. doi: 10.1007/s00253-002-1076-7
83. Suzuki T, Kusano K, Kondo N, Nishikawa K, Kuge T, Ohno N. Biological activity of high-purityβ-1,3-1,6-glucan derived from the black yeast aureobasidium pullulans: a literature review. Nutrients. (2021) 13:242. doi: 10.3390/nu13010242
84. Liu S, Zhou W, Ye W, Chen J, Wu C, Chen D, et al. Research advance on biological activity and structure-activity relationships of bioactive polysaccharide. Food Res Dev. (2017) 38:211–8.
85. Zhang L, Li X, Xu X, Zeng F. Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydr Res. (2005) 340:1515–21. doi: 10.1016/j.carres.2005.02.032
86. Yoon EJ, Yoo S-H, Cha J, Lee HG. Effect of levan's branching structure on antitumor activity. Int J Biol Macromol. (2004) 34:191–4. doi: 10.1016/j.ijbiomac.2004.04.001
87. Zhang Z, Zhang Y. Advances in molecular modification of polysaccharides. Food Ind. (2017) 38:253–7. doi: 10.19319/j.cnki.issn.1008-021x.2021.09.032
88. Jin M, Lu Z, Huang M, Wang Y, Wang Y. Sulfated modification and antioxidant activity of exopolysaccahrides produced by Enterobacter cloacae Z0206. Int J Biol Macromol. (2011) 48:607–12. doi: 10.1016/j.ijbiomac.2011.01.023
89. Jambrak R, Herceg Z, Šubarić D, Babić J, Brnčić M, Brnčić SR, et al. Ultrasound effect on physical properties of corn starch. Carbohydr Polym. (2010) 79:91–100. doi: 10.1016/j.carbpol.2009.07.051
90. Huheihel M, Ishanu V, Tal J, Arad SM. Activity of porphyridium sp. polysaccharide against herpes simplex viruses in vitro and in vivo. J Biochem Biophys Methods. (2002) 50:189–200. doi: 10.1016/S0165-022X(01)00186-5
91. Liu W, Hu C, Liu Y, Dai S, Lu W, Lv X, et al. Preparation, characterization, and α-glycosidase inhibition activity of a carboxymethylated polysaccharide from the residue of Sarcandra glabra (Thunb) Nakai. Int J Biol Macromol. (2017) 99:454–64. doi: 10.1016/j.ijbiomac.2017.02.065
92. Du X, Zhang J, Lv Z, Ye L, Yang Y, Tang Q. Chemical modification of an acidic polysaccharide (TAPA1) from Tremella aurantialba and potential biological activities. Food Chem. (2014) 143:336–40. doi: 10.1016/j.foodchem.2013.07.137
93. Xiong X, Huang G, Huang H. The antioxidant activities of phosphorylated polysaccharide from native ginseng. Int J Biol Macromol. (2019) 126:842–5. doi: 10.1016/j.ijbiomac.2018.12.266
94. Jia J, Shen J, Chen L, Gui Z, Wu Q, Zhang S. Enzymatic modification and antioxidant activity of polysaccharides from Cordyceps militaris fruit bodies. Food Sci. (2013) 34:114–20.
95. Jong WHD, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. (2008) 3:133–49. doi: 10.2147/IJN.S596
96. Chen M, Mib F, Liao Z, Hsiao C, Sonaje K, Chung M, et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev. (2012) 65:865–79. doi: 10.1016/j.addr.2012.10.010
97. Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev. (2001) 50:91–101. doi: 10.1016/S0169-409X(01)00180-6
98. Chen F, Huang G. Preparation and immunological activity of polysaccharides and their derivatives. Int J Biol Macromol. (2018) 112:211–6. doi: 10.1016/j.ijbiomac.2018.01.169
99. Jiang J, Meng F, He Z, Ning Y, Li X, Song H, et al. Sulfated modification of longan polysaccharide and its immunomodulatory and antitumor activity in vitro. Int J Biol Macromol. (2014) 67:323–9. doi: 10.1016/j.ijbiomac.2014.03.030
100. Ma L, Chen H, Zhang Y, Zhang N, Fu L. Chemical modification and antioxidant activities of polysaccharide from mushroom Inonotus obliquus. Carbohydr Polym. (2012) 89:371–8. doi: 10.1016/j.carbpol.2012.03.016
101. Li S, Xiong Q, Lai X, Li X, Wan M, Zhang J, et al. Molecular modification of polysaccharides and resulting bioactivities. Compr Rev Food Sci Food Saf. (2016) 15:237–50. doi: 10.1111/1541-4337.12161
102. Wang J, Yang T, Tian J, Zeng T, Wang X, Yao J, et al. Synthesis and characterization of phosphorylated galactomannan: the effect of DS on solution conformation and antioxidant activities. Carbohydr Polym. (2014) 113:325–35. doi: 10.1016/j.carbpol.2014.07.028
103. Deng C, Fu H, Xu J, Shang J, Cheng Y. Physiochemical and biological properties of phosphorylated polysaccharides from Dictyophora indusiata. Int J Biol Macromol. (2015) 72:894–9. doi: 10.1016/j.ijbiomac.2014.09.053
104. Cheng L, Wang Y, He X, Wei X. Preparation, structural characterization and bioactivities of Se-containing polysaccharide: a review. Int J Biol Macromol. (2018) 120:82–92. doi: 10.1016/j.ijbiomac.2018.07.106
105. Gao P, Bian J, Xu S, Liu C, Sun Y, Zhang G, et al. Structural features, selenization modification, antioxidant and anti-tumor effects of polysaccharides from alfalfa roots. Int J Biol Macromol. (2020) 149:207–14. doi: 10.1016/j.ijbiomac.2020.01.239
106. Zheng N, Ruan J, Zhang Y, Ge Z, Qiao S, Yao X. Absorption of polysaccharide from rehmannia liuwei in mice. Chinese Pharmacol Bull. (2000) 16:403–5. doi: 10.3321/j.issn:1001-1978.2000.04.013
107. Zhang Y, Liu J, Dou P, Wu Z, Zheng Z, Pan X, et al. Oral absorption characteristics mechanisms of a pectin-type polysaccharide from Smilax china L. across the intestinal epithelium. Carbohydr Polym. (2021) 270:118383. doi: 10.1016/j.carbpol.2021.118383
108. Eliaz I, Raz A. Pleiotropic effects of modified citrus pectin. Nutrients. (2019) 11:2619. doi: 10.3390/nu11112619
109. Cao N, Zhao Z, Zhao Y, Jiang T, Chu J, Zhang Y, et al. Study on degradation and intestinal absorption of Poria cocos Polysaccharides in artificial gastric juice and intestinal juice. Sci Technol Food Ind. (2020) 41:299–303.
110. Englyst KN. Englyst HN. Carbohydrate bioavailability. Br J Nutr. (2005) 94:1–11. doi: 10.1079/BJN20051457
111. Q. Han. Critical problems stalling progress in natural bioactive polysaccharide research and development. J Agric Food Chem. (2018) 66:4581–3. doi: 10.1021/acs.jafc.8b00493
112. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Sci Technol Inf. (2005) 307:1915–20. doi: 10.1126/science.1104816
113. Liu Z, Wang L, Chen M. Utilization and metabolism of polysaccharides in intestinal flora. Acta Microbiol Sin. (2020) 61:1816–28. doi: 10.13343/j.cnki.wsxb.20200478
114. Nepelska M, Cultrone A, Béguet-Crespel F, Roux KL, Doré J, Arulampalam V, et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS ONE. (2012) 7:e52869. doi: 10.1371/journal.pone.0052869
115. Li L, Yao H, Li X, Zhang Q, Wu X, Wong T, et al. Destiny of dendrobium officinale polysaccharide after oral administration: indigestible and nonabsorbing, ends in modulating gut microbiota. J Agric Food Chem. (2019) 67:5968–77. doi: 10.1021/acs.jafc.9b01489
116. McClements DJ, Xiao H. Designing food structure and composition to enhance nutraceutical bioactivity to support cancer inhibition. Semin Cancer Biol. (2017) 46:215–26. doi: 10.1016/j.semcancer.2017.06.003
117. Huang R, Shen S, Chen H, Wu W, Chen S, Ye X. Recent advances in bioactivities and technologies for bioavailability improvement of Citrus Flavonoids. Food Sci Nutr. (2019) 40:319–26.
118. Lai J, Liao Z, Yang M, Liang X. Research and progress of bioavailability. Chinese J Exp Tradit Med Formulae. (2010) 16:226–9.
119. Wang Y, Zhang J, Jiang J, Xing M, Cao Q, Liang H, et al. Advances in oral absorption of natural active polysaccharides. Chem Life. (2019) 39:605–10.
120. Norouzi M, Nazari B, Miller DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. (2016) 21:1835–49. doi: 10.1016/j.drudis.2016.07.006
121. Zhou Y, Yang Y, Wang S, Wang Y. Research progress of natural active polysaccharides in biomedicine. Polym Bull. (2006) 9:16–22. doi: 10.14028/j.cnki.1003-3726.2006.09.002
122. Yu Y, Shen M, Song Q, Xie J. Biological activities and pharmaceutical applications of polysaccharide from natural resources: a review. Carbohydr Polym. (2018) 183:91–101. doi: 10.1016/j.carbpol.2017.12.009
123. Zong A, Cao H, Wang F. Anticancer polysaccharides from natural resources: A review of recent research. Carbohydr Polym. (2012) 90:1395–410. doi: 10.1016/j.carbpol.2012.07.026
124. Deepika MS, Thangam R, Sheena TS, Sasirekha R, Sivasubramanian S, Babu MD, et al. A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis. Biomed Pharmacotherapy. (2019) 109:1181–95. doi: 10.1016/j.biopha.2018.10.178
125. Sun B, Yu S, Zhao D, Guo S, Wang X, Zhao K. Polysaccharides as vaccine adjuvants. Vaccine. (2018) 36:5226–34. doi: 10.1016/j.vaccine.2018.07.040
126. Sharma C, Bhardwaj N, Sharma A, Tuli HS, Batra P, Beniwal V, et al. Bioactive metabolites of Ganoderma lucidum: Factors, mechanism and broad spectrum therapeutic potential. J Herb Med. (2019) 17–18:100268. doi: 10.1016/j.hermed.2019.100268
127. Jiang Y, Chang Y, Liu Y, Zhang M, Luo H, Hao C, et al. Overview of Ganoderma sinense polysaccharide-an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China. Biomed Pharmacotherapy. (2017) 96:865–70. doi: 10.1016/j.biopha.2017.09.060
128. Debele TA, Mekuria SL, Tsai H-C. Polysaccharide based nanogels in the drug delivery system: Application as the carrier of pharmaceutical agents. Mater Sci Eng C Mater Biol Appl. (2016) 68:964–81. doi: 10.1016/j.msec.2016.05.121
129. Park BK, Kim M-M. Applications of chitin and its derivatives in biological medicine. Int J Mol Sci. (2010) 11:5152–64. doi: 10.3390/ijms11125152
130. Zhang Y, Sun T, Jiang C. Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharm Sin B. (2018) 8:34–50. doi: 10.1016/j.apsb.2017.11.005
131. Oliveira C, Neves NM, Reis RL, Martins A, Silva TH. A. review on fucoidan antitumor strategies: From a biological active agent to a structural component of fucoidan-based systems. Carbohydr Polym. (2020) 239:116131. doi: 10.1016/j.carbpol.2020.116131
132. Gupta N, Jangid AK, Pooja D, Kulhari H. Inulin: A novel and stretchy polysaccharide tool for biomedical and nutritional applications. Int J Biol Macromol. (2019) 132:852–63. doi: 10.1016/j.ijbiomac.2019.03.188
133. Zhang Y, Wang C, Liu C, Wang X, Chen B, Yao L, et al. Recent developments in stigma maydis polysaccharides: Isolation, structural characteristics, biological activities and industrial application. Int J Biol Macromol. (2020) 150:246–52. doi: 10.1016/j.ijbiomac.2020.01.294
134. Giavasis I. Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals. Curr Opin Biotechnol. (2014) 26:162–73. doi: 10.1016/j.copbio.2014.01.010
Keywords: cancer, polysaccharides, anti-tumor activity, structure-activity relationship, molecular mechanisms
Citation: Guo R, Chen M, Ding Y, Yang P, Wang M, Zhang H, He Y and Ma H (2022) Polysaccharides as Potential Anti-tumor Biomacromolecules —A Review. Front. Nutr. 9:838179. doi: 10.3389/fnut.2022.838179
Received: 17 December 2021; Accepted: 27 January 2022;
Published: 28 February 2022.
Edited by:
Jaspreet Singh, Massey University, New ZealandReviewed by:
Sarana Rose Sommano, Chiang Mai University, ThailandPaola Aiello, Sapienza University of Rome, Italy
Copyright © 2022 Guo, Chen, Ding, Yang, Wang, Zhang, He and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuanqing He, eXFoZSYjeDAwMDQwO3Vqcy5lZHUuY24=